Sutro Biopharma, Inc. · NASDAQ:STRO

Affinity Asset Advisors, LLC reported a 6.50% stake in Sutro Biopharma, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 14, 2026

Affinity Asset Advisors, LLC reported a 6.50% stake in Sutro Biopharma, Inc., 1,069,519 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).

Stake
6.50%
Shares
1,069,519
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC6.50%1,069,519
Michael Cho6.50%1,069,519

Source

View original at SEC

Related